Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan

Oct 1, 2018 6:00 PM ET

Last year, in partnership with Mastercard and the World Hepatitis Alliance, we launched a pilot program in Pakistan to simplify the delivery of HCV treatment in a resource-limited setting with high disease burden.

Learn more in the video above.

Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan

More from Gilead Sciences

Looking Back to the Future: Gilead’s Long-Standing Commitment To Help End the HIV Epidemic

Gilead Sciences - Born With HIV in the 80s: Kim’s Story of Growing Up as a Dandelion

Gilead Researcher Awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award

Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of “The Centrifuge Sessions”

"The Adventure Jar” - A Children’s Book Supporting Families Impacted by Metastatic Breast Cancer (MBC) Receives Two 2025 Bronze Anvil Awards

Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden

Transforming How Cancer Is Treated: Research Results To Be Shared at ASCO25

Gilead Sciences and Kite Pharma To Announce Transformative Cancer Research at This Year’s American Society of Clinical Oncology (ASCO) Annual Meeting